| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 8.983 | 64.957 | 83.815 | 99.966 | 167.977 |
| Total Income - EUR | - | - | - | - | - | 8.983 | 64.957 | 83.815 | 101.772 | 167.977 |
| Total Expenses - EUR | - | - | - | - | - | 9.648 | 38.652 | 53.212 | 93.831 | 121.088 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -665 | 26.305 | 30.603 | 7.941 | 46.889 |
| Net Profit/Loss - EUR | - | - | - | - | - | -755 | 25.655 | 29.753 | 6.923 | 41.850 |
| Employees | - | - | - | - | - | 2 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Dr. Anas Alaraj S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 9.808 | 23.856 | 24.623 | 142.787 |
| Current Assets | - | - | - | - | - | 624 | 37.136 | 46.328 | 39.836 | 50.364 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 32.965 | 33.022 | 14.551 | 2.684 |
| Cash | - | - | - | - | - | 624 | 4.171 | 13.305 | 25.285 | 47.681 |
| Shareholders Funds | - | - | - | - | - | -714 | 24.957 | 54.788 | 61.544 | 95.110 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.338 | 21.987 | 15.396 | 2.915 | 98.042 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Anas Alaraj S.r.l.